Cancer-Net BCa: Breast Cancer Pathologic Complete Response Prediction using Volumetric Deep Radiomic Features from Synthetic Correlated Diffusion Imaging
share
Breast cancer is the second most common type of cancer in women in Canada and the United States, representing over 25 Neoadjuvant chemotherapy treatment has recently risen in usage as it may result in a patient having a pathologic complete response (pCR), and it can shrink inoperable breast cancer tumors prior to surgery so that the tumor becomes operable, but it is difficult to predict a patient's pathologic response to neoadjuvant chemotherapy. In this paper, we investigate the efficacy of leveraging learnt volumetric deep features from a newly introduced magnetic resonance imaging (MRI) modality called synthetic correlated diffusion imaging (CDI^s) for the purpose of pCR prediction. More specifically, we leverage a volumetric convolutional neural network to learn volumetric deep radiomic features from a pre-treatment cohort and construct a predictor based on the learnt features using the post-treatment response. As the first study to explore the utility of CDI^s within a deep learning perspective for clinical decision support, we evaluated the proposed approach using the ACRIN-6698 study against those learnt using gold-standard imaging modalities, and found that the proposed approach can provide enhanced pCR prediction performance and thus may be a useful tool to aid oncologists in improving recommendation of treatment of patients. Subsequently, this approach to leverage volumetric deep radiomic features (which we name Cancer-Net BCa) can be further extended to other applications of CDI^s in the cancer domain to further improve prediction performance.
READ FULL TEXT
